BLANDIZZI, CORRADO
 Distribuzione geografica
Continente #
NA - Nord America 36.870
AS - Asia 15.767
EU - Europa 12.681
SA - Sud America 2.273
Continente sconosciuto - Info sul continente non disponibili 991
AF - Africa 727
OC - Oceania 64
Totale 69.373
Nazione #
US - Stati Uniti d'America 35.796
SG - Singapore 4.755
CN - Cina 4.377
IT - Italia 4.125
HK - Hong Kong 2.477
SE - Svezia 2.078
BR - Brasile 1.871
VN - Vietnam 1.366
DE - Germania 1.305
BG - Bulgaria 1.067
GB - Regno Unito 825
CA - Canada 756
TR - Turchia 695
FR - Francia 652
FI - Finlandia 576
UA - Ucraina 559
RU - Federazione Russa 532
IN - India 433
KR - Corea 404
JP - Giappone 297
CI - Costa d'Avorio 267
AT - Austria 242
CH - Svizzera 202
BD - Bangladesh 150
IQ - Iraq 123
AR - Argentina 120
MX - Messico 118
NL - Olanda 116
ID - Indonesia 103
NG - Nigeria 95
SN - Senegal 95
PK - Pakistan 85
BE - Belgio 84
PL - Polonia 82
UZ - Uzbekistan 75
ZA - Sudafrica 66
SA - Arabia Saudita 64
VE - Venezuela 63
CO - Colombia 60
EC - Ecuador 59
AU - Australia 56
ES - Italia 48
MY - Malesia 46
PH - Filippine 44
CR - Costa Rica 40
JM - Giamaica 40
MA - Marocco 39
EG - Egitto 32
KE - Kenya 32
AZ - Azerbaigian 29
JO - Giordania 28
AE - Emirati Arabi Uniti 27
PY - Paraguay 27
PE - Perù 26
CL - Cile 25
PT - Portogallo 24
TH - Thailandia 23
LT - Lituania 21
NP - Nepal 20
TN - Tunisia 20
HN - Honduras 18
TT - Trinidad e Tobago 18
GR - Grecia 17
BJ - Benin 16
IL - Israele 16
NI - Nicaragua 16
IE - Irlanda 15
KZ - Kazakistan 15
IR - Iran 14
CZ - Repubblica Ceca 13
OM - Oman 13
RO - Romania 13
TW - Taiwan 13
EU - Europa 12
KG - Kirghizistan 12
PA - Panama 12
DZ - Algeria 11
ET - Etiopia 11
PS - Palestinian Territory 11
AL - Albania 10
BB - Barbados 10
DO - Repubblica Dominicana 10
GT - Guatemala 10
UY - Uruguay 10
BY - Bielorussia 9
LB - Libano 9
BO - Bolivia 8
DK - Danimarca 8
NO - Norvegia 8
NZ - Nuova Zelanda 8
SV - El Salvador 8
AO - Angola 7
LV - Lettonia 7
RS - Serbia 7
SY - Repubblica araba siriana 7
GE - Georgia 6
HU - Ungheria 6
KH - Cambogia 6
SI - Slovenia 6
BS - Bahamas 5
Totale 68.293
Città #
Ashburn 3.846
Woodbridge 3.259
Ann Arbor 2.758
Singapore 2.668
Hong Kong 2.427
Fairfield 2.365
Houston 2.061
Chandler 1.942
San Jose 1.667
Santa Clara 1.630
Dallas 1.500
Sofia 1.062
Milan 928
Shanghai 909
Seattle 907
Beijing 900
Wilmington 845
Cambridge 806
Serra 796
New York 745
Council Bluffs 654
Jacksonville 654
Ottawa 537
Los Angeles 525
Boardman 516
Hefei 509
Princeton 456
Lawrence 407
Izmir 392
Seoul 376
Lauterbourg 372
Medford 359
Nanjing 315
Ho Chi Minh City 291
Abidjan 267
Tokyo 267
Des Moines 256
Florence 230
London 220
Hanoi 217
Dong Ket 213
Istanbul 201
Dearborn 190
São Paulo 185
Buffalo 180
Bern 175
Vienna 172
Frankfurt am Main 157
Helsinki 157
Munich 143
Redondo Beach 132
Rome 132
Nanchang 121
Pisa 117
Redwood City 115
The Dalles 114
Jüchen 113
Columbus 112
San Diego 108
Bremen 107
Chicago 99
Dakar 95
Lagos 90
Brussels 81
Toronto 79
Falls Church 77
Lancaster 77
Turku 76
Orem 75
Rio de Janeiro 74
Phoenix 72
Washington 72
Kunming 69
Marseille 65
Norwalk 65
Ogden 65
Tashkent 65
Shenyang 60
Hebei 59
Tianjin 59
Boulder 56
San Francisco 56
Atlanta 55
Changsha 54
Montreal 54
Warsaw 54
Düsseldorf 53
Pune 51
Jakarta 49
Belo Horizonte 48
Brooklyn 45
Jiaxing 45
Chennai 44
Da Nang 43
Curitiba 42
Baghdad 41
Denver 41
Guangzhou 40
Haiphong 40
Fuzhou 38
Totale 47.208
Nome #
Derivati isoindolici come attivatori di AMPK 547
Fatal hepatitis after long-term pulse itraconazole treatment for onychomycosis: a case report with review of literature 416
Telogen effluvium following bivalent human papilloma virus vaccine administration: a report of two cases 352
Preparation of isoindoline derivatives for use as AMPK activators 352
Functional evidence that alpha-2A-adrenoceptors are responsible for anti-lipolysis in human abdominal cells 337
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 311
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis. 310
Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon 285
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 283
Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers 281
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment 279
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 279
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 277
Derivati benzofuranici come attivatori di AMPK 271
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis 269
Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient 265
Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis 264
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 256
A selective antimuscarinic agent: pirenzepine. Review of its pharmacologic and clinical properties 256
Immunohistochemical Analysis of Myenteric Ganglia and Interstitial Cells of Cajal in Ulcerative Colitis 249
The Anti-TNF Drugs and the Risk of Lymphoma, Skin Cancer and Melanoma: A Signal Detection Analysis 248
Mast cell neuromuscolar involvement in patients with severe gastrointestinal dysmotility (SGID) 247
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 247
Effects of suramin on gastric ulceration and EGF content of submandibular glands 242
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 240
Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers 240
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 237
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 236
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 234
Connective remodelling in the colonic neuromuscular compartment of patients with ulcerative colitis 231
Altered expression pattern of molecular factors involved in colonic smooth muscle functions : an immunohistochemical study in patients with diverticular disease 231
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year 230
Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations 228
Fisiopatologia e farmacologia del vomito 227
Alpha-2 adrenoceptors and gastric secretion in dogs: The role of gastrin 226
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 223
Excitatory and inhibitory cholinergic effects of yohimbine on isolated guinea-pig small intestine 222
Gabapentin-induced severe myopathy: a case report 222
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 222
Fibrotic and Vascular Remodelling of Colonic Wall in Patients with Active Ulcerative Colitis 221
Periodontal tissue disposition of azithromycin 220
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 218
Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon 216
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 216
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome 216
Characterization of mechanisms accounting for COX-2-mediated proliferative actions of gastrin on human colon cancer cells 214
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 213
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic 212
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation 212
Alpha-2A adrenoceptor subtypes modulate cholinergic contractile activity of guinea-pig ileum 211
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 211
Inducible Nitric Oxide Synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats 211
Anti-CD73 in cancer immunotherapy: awakening new opportunities 211
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects 211
Alpha-2 adrenoceptors and gastric secretion in dogs: the role of gastrin 210
Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron 209
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 209
Quinolonecarboxylic acid derivatives as GABA-A receptor antagonists 208
Role of a2-adrenoceptors on gastrin release in the dog 208
Cyclooxygenase expression in neuromuscular compartment of normal and inflamed colon 208
A1 and A2a receptors mediate inhibitory rffects of adenosine on the motor activity of human colon 208
Improved tonsillar disposition of azithromycin following a three-day oral treatment with 20 mg kg-1 in paediatric patients 207
Effect of a novel mucoadhesive polysaccharide obtained from tamarind seeds on the intraocular penetration of gentamicin and ofloxacin in rabbits 205
Role of Cyclooxygenase isoforms in the neuromodulation of colonic motility in Humans and Mice 204
Neuromodulation of colonic motility by cycloxygenase isoforms in the presence of experimental bowel inflammation 204
Alteration of endogenous purinergic modulation of tracheal neurotransmission in sensitised guinea-pigs 203
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district 203
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy 203
Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients 203
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 203
Targeting enteric neuroplasticity: Diet and bugs as new key factors 202
Cyclooxygenase inhibitors modulate pro-fibrotic signalling mediated by TGFbeta in experimental colitis 202
Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy) 202
Aging Modulates the Influence of Arginase on Endothelial Dysfunction in Obesity 201
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients 201
Molecular cloning of the canine gastrin/CCK-B receptor gene 200
Efficay and tolerability of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug: a review 199
Colonic smooth muscle cells and interstitial cells of Cajal in diverticular disease 198
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 197
Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers 197
AMPK Activators as Novel Drug Candidates for the Treatment of Inflammatory Bowel Diseases 197
Enteric protective effects of the combination Bifidobacterium longum and lactoferrin in a rat model of diclofenac-induced intestinal injury. 197
GABA-A-mediated gastrin release induced by baclofen in the isolated vascularly perfused rat stomach 196
PERIODONTAL TISSUE DISTRIBUTION OF CEFPODOXIME PROXETIL AND EFFICACY IN ACUTE ODONTOGENIC INFECTIONS 196
A tonic inhibitory control of rat pepsin secretion is mediated by central GABA-A receptors 196
Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials 195
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 195
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 195
Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients 193
Effects of pantoprazole on ulcer healing delay associated with NSAID treatment 193
Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients 193
Enteric alpha-2 adrenoceptors: pathophysiological implications in functional and inflammatory bowel disorders 192
Genetic polymorphisms of thiopurine S-methyltransferase in a cohort of patients with systemic autoimmune diseases 192
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 192
Role of A2a adenosine in the regulation of colonic motility in normal human colon 191
Characterization of a novel mechanism accounting for the adverse cholinergic effects of the anticancer drug irinotecan. 191
CCK-1 and CCK-2 receptors regulate gastric pepsinogen secretion 191
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 191
Modulation of gastric acid secretion by peripheral presynaptic alpha-2 adrenoceptors at both sympathetic and parasympathetic pathways 190
Healthy volunteers and early phases of clinical experimentation 190
Totale 22.945
Categoria #
all - tutte 201.575
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 201.575


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.427 0 0 190 359 871 681 144 269 220 158 259 1.276
2022/20236.157 736 833 401 592 682 848 89 457 1.051 42 387 39
2023/20244.461 575 467 549 303 639 774 170 164 70 118 192 440
2024/202513.205 67 509 183 810 1.208 1.356 1.075 647 1.332 1.826 1.440 2.752
2025/202613.860 1.077 1.766 1.711 991 1.412 1.257 2.212 629 835 1.293 422 255
2026/20274.294 828 1.581 1.885 0 0 0 0 0 0 0 0 0
Totale 69.373